Primary Sclerosing Cholangitis - 31 Studies Found
Active, not recruiting |
: Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects : Primary Sclerosing Cholangitis : 2013-02-21 : Drug: Oral Vancomycin Other Name: Vancocin |
Terminated |
: Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC) : Primary Sclerosing Cholangitis : 2009-08-04 : Drug: Thalidomide Titrate to 400 mg daily for 6 months |
Not yet recruiting |
: A Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis : Primary Sclerosing Cholangitis : 2016-05-17 : Drug: hymecromone hymecromone treatment as described |
Recruiting |
: Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis : Primary Sclerosing Cholangitis : 2012-09-10 :
|
Recruiting |
: Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients : Primary Sclerosing Cholangitis : 2015-10-31 :
|
Completed |
: A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis : Primary Sclerosing Cholangitis : 2010-03-10 :
|
Recruiting |
: A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis : Primary Sclerosing Cholangitis : 2016-11-22 : Drug: Curcumin Subjects will receive one 750 mg softgel by mouth twice a day for 12 weeks. Each each 750 |
Completed |
: Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis : Primary Sclerosing Cholangitis : 2012-12-19 :
|
Completed |
: Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis : Primary Sclerosing Cholangitis : 2011-04-25 :
|
Active, not recruiting |
: Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis : Primary Sclerosing Cholangitis : 2016-02-29 :
|